Biological Therapy Analysis & Statistics, December 2014 (p7)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

181-210 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H2 2014

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H2 ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States, World
Bone Fracture - Pipeline Review, H2 2014

Bone Fracture - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Bone Fracture - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Bone Fracture - Pipeline Review, H2 2014’, provides an overview of the Bone Fracture’s therapeutic pipeline. This report ...

  • Industries : Pharmaceutical, Biological Therapy
  • Countries : World
Kite Pharma, Inc. - Product Pipeline Review - 2014

Kite Pharma, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Kite Pharma, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Kite Pharma, Inc. - Product Pipeline Review - 2014’, provides an overview of the Kite Pharma, Inc.’s pharmaceutical ...

  • Industries : Research and Development, Pathology, Biological Therapy, Biopharmaceutical, Biotechnology
  • Countries : United States
ReGenX Biosciences, LLC - Product Pipeline Review - 2014

ReGenX Biosciences, LLC - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

ReGenX Biosciences, LLC - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘ReGenX Biosciences, LLC - Product Pipeline Review - 2014’, provides an overview of the ReGenX Biosciences, ...

  • Industries : Research and Development, Biological Therapy
  • Countries : United States
Kaken Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014

Kaken Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Kaken Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Kaken Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014’, provides an overview of the Kaken ...

  • Industries : Pharmaceutical
  • Countries : World
Stem Cell Technologies and Applications: World Industry and Market Outlook 2015-2025

Stem Cell Technologies and Applications: World Industry and Market Outlook 2015-2025

  • $ 2 676
  • Industry report
  • December 2014
  • by Visiongain

Report Details Stem cells, an expanding market with vast potential – explore developments and commercial prospects What does the future hold for that cellular technology? What progress and sales are ...

  • Industries : Biological Therapy
  • Countries : World
Isis Pharmaceuticals, Inc. - Strategy and SWOT Report

Isis Pharmaceuticals, Inc. - Strategy and SWOT Report

  • $ 175
  • Company report
  • December 2014
  • by MarketLine

Isis Pharmaceuticals, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service ...

  • Industries : Pharmaceutical
  • Countries : United States
Blood Disease Drugs Markets in China

Blood Disease Drugs Markets in China

  • $ 4 000
  • Industry report
  • December 2014
  • by Asia Market Information & Development Company

China's demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth ...

  • Industries : Drug and Medication, Pharmaceutical, Pathology
  • Countries : China
Gene Therapy Partnering Terms and Agreements

Gene Therapy Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • December 2014
  • by Currentpartnering

The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in ...

  • Industries : Biological Therapy
Pneumonia Treatment Drugs Markets in China

Pneumonia Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • December 2014
  • by Asia Market Information & Development Company

China's demand for Pneumonia Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : China
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014’, provides an overview of the Retinitis Pigmentosa ...

  • Industries : Pathology, Pharmaceutical, Biological Therapy
  • Countries : United States
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014’, provides an overview of the Chemotherapy ...

  • Industries : Pharmaceutical, General Medicine and Specialty Medicine, Therapy, Healthcare, Biological Therapy, Biotechnology
  • Countries : World, United States
Critical Limb Ischemia - Pipeline Review, H2 2014

Critical Limb Ischemia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Critical Limb Ischemia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Critical Limb Ischemia - Pipeline Review, H2 2014’, provides an overview of the Critical Limb Ischemia’s therapeutic ...

  • Industries : Pathology, Pharmaceutical, Biological Therapy
  • Countries : United States
Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2014

Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2014’, provides an overview of the Allergic Rhino-C ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication, Research and Development
  • Countries : World
Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2014

Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2014’, provides an overview of the Dry (Atrophic) ...

  • Industries : General Medicine and Specialty Medicine, Healthcare, Pharmaceutical
  • Countries : United States
Degenerative Disc Disease - Pipeline Review, H2 2014

Degenerative Disc Disease - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Degenerative Disc Disease - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Degenerative Disc Disease - Pipeline Review, H2 2014’, provides an overview of the Degenerative Disc Disease’s ...

  • Industries : Biological Therapy, Pharmaceutical
  • Countries : United States
Mesoblast Limited - Product Pipeline Review - 2014

Mesoblast Limited - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • November 2014
  • by Global Markets Direct

Mesoblast Limited - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Mesoblast Limited - Product Pipeline Review - 2014’, provides an overview of the Mesoblast Limited’s pharmaceutical ...

  • Industries : Research and Development, Pathology, Biological Therapy
  • Countries : United States
Kasiak Research Pvt. Ltd. - Product Pipeline Review - 2014

Kasiak Research Pvt. Ltd. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • November 2014
  • by Global Markets Direct

Kasiak Research Pvt. Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Kasiak Research Pvt. Ltd. - Product Pipeline Review - 2014’, provides an overview of the Kasiak Research ...

  • Industries : Research and Development, Biological Therapy, Pathology
  • Countries : World
Escape Therapeutics, Inc. - Product Pipeline Review - 2014

Escape Therapeutics, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • November 2014
  • by Global Markets Direct

Escape Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Escape Therapeutics, Inc. - Product Pipeline Review - 2014’, provides an overview of the Escape Therapeutics, ...

  • Industries : Therapy, Research and Development, Pharmaceutical
  • Countries : World
RXi Pharmaceuticals Corporation - Product Pipeline Review - 2014

RXi Pharmaceuticals Corporation - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • November 2014
  • by Global Markets Direct

RXi Pharmaceuticals Corporation - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘RXi Pharmaceuticals Corporation - Product Pipeline Review - 2014’, provides an overview of the RXi ...

  • Industries : Pharmaceutical, Research and Development, Pathology
  • Countries : United States
AmStem Corporation - Strategic SWOT Analysis Review

AmStem Corporation - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary AmStem Corporation is formerly known as Stem Cell Therapy International, Inc. (SCTI) is a biotechnology company, engaged in the field of regenerative medicines. The company offers products, which ...

Stem Cell Innovations, Inc. (SCLL) - Strategic SWOT Analysis Review

Stem Cell Innovations, Inc. (SCLL) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Stem Cell Innovations, Inc. (SCI) is a privately held biotechnology company, based in the US. The company is engaged in the discovery and development of human cell based drugs. Its core technologies ...

  • Industries : Biological Therapy
Chemokine Therapeutics Corp. (CTI) - Strategic SWOT Analysis Review

Chemokine Therapeutics Corp. (CTI) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Chemokine Therapeutics Corp. (Chemokine Therapeutics) is a publicly held biotechnology company. It is engaged in the discovery and develops peptide analogs of chemokines for cancer treatment and ...

  • Industries : Biological Therapy, Therapy
Dendritic Cell and CAR-T Therapies Market, 2014 - 2024

Dendritic Cell and CAR-T Therapies Market, 2014 - 2024

  • $ 1 899
  • Industry report
  • November 2014
  • by Roots Analysis Private Ltd.

INTRODUCTION Cancer is known to be one of the leading causes of death worldwide. The field of oncology is vast and comprises several indications, including some rare / orphan forms. Although oncology continues ...

  • Industries : Pharmaceutical, Biological Therapy, Therapy, Biotechnology, Motor Vehicle, Pathology, Hospitality, Hospitality, Automotive
  • Countries : United States
Intracerebral Hemorrhage - Pipeline Review, H2 2014

Intracerebral Hemorrhage - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Intracerebral Hemorrhage - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Intracerebral Hemorrhage - Pipeline Review, H2 2014’, provides an overview of the Intracerebral Hemorrhage’s ...

  • Industries : Pharmaceutical, Pathology
  • Countries : United States, World
Epstein-Barr Viral Infections - Pipeline Review, H2 2014

Epstein-Barr Viral Infections - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Epstein-Barr Viral Infections - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Epstein-Barr Viral Infections - Pipeline Review, H2 2014’, provides an overview of the Epstein-Barr Viral ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2014

Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2014’, provides an overview of the Microscopic Polyangiitis ...

  • Industries : Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : World, United States
Wegener%s Granulomatosis - Pipeline Review, H2 2014

Wegener%s Granulomatosis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Wegener's Granulomatosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Wegener's Granulomatosis - Pipeline Review, H2 2014’, provides an overview of the Wegener's Granulomatosis’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World
Acute Lung Injury - Pipeline Review, H2 2014

Acute Lung Injury - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Acute Lung Injury - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Acute Lung Injury - Pipeline Review, H2 2014’, provides an overview of the Acute Lung Injury’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Liver Cirrhosis - Pipeline Review, H2 2014

Liver Cirrhosis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Liver Cirrhosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Liver Cirrhosis - Pipeline Review, H2 2014’, provides an overview of the Liver Cirrhosis’s therapeutic pipeline. This ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States, World

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.